Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular markers in malignant cutaneous melanoma: gift horse or one-trick pony?

Journal of cellular biochemistry - 15 Oct 2005

Martinez Steve R, Hoon Dave S B

Abstract excerpt

The management of malignant cutaneous melanoma is problematic. Current clinical prognostic factors do not adequately predict disease recurrence and overall survival in a significant subset of patients. Adjuvant therapies for melanoma are notoriously toxic and associated with significant morbidity. Furthermore, it has been difficult to predict which patients will respond best to these treatments, if at all. DNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemotherapy, Adjuvant
Share to DNA Methylation
Share to Epigenesis, Genetic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Melanoma

Share to Neoplasm Metastasis

Share to Sensitivity and Specificity

Share to Skin Neoplasms

Share to Survival Rate

Source

Identifiers

PMID: 16088931
DOI: 10.1002/jcb.20556

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular markers in malignant cutaneous melanoma: gift horse or one-trick pony?PMID 16088931Read ↗

Molecular markers in melanomaSemantic proximity Read ↗

Prognostic and predictive biomarkers in melanoma: an updateSemantic proximity Read ↗

Tumor Biomarkers in MelanomaSemantic proximity Read ↗

Molecular diagnosis of melanoma-have we arrived?Semantic proximity Read ↗

Prognostic biomarkers in melanoma: a 2023 update from clinical trials in different therapeutic scenarios.Semantic proximity Read ↗

Unraveling the Wide Spectrum of Melanoma BiomarkersSemantic proximity Read ↗

Cutaneous melanoma in the era of molecular profiling.Semantic proximity Read ↗

New strategies in melanoma: molecular testing in advanced disease.Semantic proximity Read ↗

Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy.Semantic proximity Read ↗

Prognostic Testing in Uveal Melanoma by Transcriptomic Profiling of Fine Needle Biopsy SpecimensSemantic proximity Read ↗

Use of a prognostic gene expression profile test for T1 cutaneous melanoma: Will it help or harm patients?Semantic proximity Read ↗

Classification of node-positive melanomas into prognostic subgroups using keratin, immune, and melanogenesis expression patternsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.